Cassandra Pollard Joins Millipore Sigma as an Associate Scientist II September 5, 2024 Cassandra Pollard joins Millipore Sigma as an Associate Scientist II. At Millipore Sigma, a leading life science [….]
Ken Herko Joins PAK BioSolutions as New Operations Manager August 7, 2024 Ken Herko joins PAK BioSolutions as New Operations Manager. Ken Herko is a seasoned professional with extensive experience [….]
We are looking to fill full-time opportunities in multiple groups such as: Must successfully complete an employment-related drug screen, complete a favorable background check, and sign and agree to the [….]
Corporate Executives are Driving Change and Focusing Their Teams on Patients
On Demand Pharmaceuticals Commissions State-of-the-Art, cGMP Medicine Manufacturing Facility The facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency [….]
Activation Capital, a leading entrepreneurship and ecosystem development organization, announced the launch of a cluster accelerator to catalyze the growth of advanced pharmaceutical manufacturing and R&D in Central Virginia. A coalition of private-public entities from Greater Petersburg and Greater Richmond helped form the accelerator, secured $2.5M in seed funding from GO Virginia and others, and appointed Activation Capital as the organizing entity – a first-of-its-kind initiative for the Commonwealth of Virginia.
Montgomery College, Maryland’s largest and most diverse community college, provides the BioHealth Capital Region with dozens of qualified research and manufacturing associates each year.
Matan Companies chose the right time to enter the life sciences manufacturing sector of real estate. The Frederick-based real estate developer is well on its way to delivering the 2 million square feet of manufacturing space it promised through Progress Labs, a project dedicated exclusively to spec properties for life sciences manufacturing.
Emergent Biosolutions’ vaccine manufacturing plant in Baltimore has been the subject of many headlines this past year for its’ role in producing several COVID-19 Vaccines. However, the history of this facility goes back more than two decades.
With the opening of its state-of-the-art facility in Rockville in 2017, GSK has been strengthening its manufacturing presence in the US. As a result, the site’s portfolio of programs and bulk production has been growing steadily, with
